To determine if class-3 semaphorins have the potential to be used as drugs for the treatment of brain cancer we expressed all the recombinant semaphorins, with the exception of sema3C, in U87MG glioblastoma derived cells. The gene discussed is SEMA3C; the disease is brain cancer.